loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Elagolix, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Elagolix

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: Elagolix sodium salt, 832720-36-2, Orlissa, Elagolix sodium [usan], Nbi-56418 na, Nbi-56418-na
    Molecular Formula
    C32H29F5N3NaO5
    Molecular Weight
    653.6  g/mol
    InChI Key
    DQYGXRQUFSRDCH-UQIIZPHYSA-M
    FDA UNII
    5948VUI423
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    sodium;4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate
    2.1.2 InChI
    InChI=1S/C32H30F5N3O5.Na/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33;/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42);/q;+1/p-1/t25-;/m0./s1
    2.1.3 InChI Key
    DQYGXRQUFSRDCH-UQIIZPHYSA-M
    2.1.4 Canonical SMILES
    CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)[O-])C4=C(C(=CC=C4)OC)F.[Na+]
    2.1.5 Isomeric SMILES
    CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)[O-])C4=C(C(=CC=C4)OC)F.[Na+]
    2.2 Other Identifiers
    2.2.1 UNII
    5948VUI423
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Elagolix

    2. Orilissa

    3. R-(+)-4-(2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2h-pyrimidin-1-yl)-1-phenylethylamino)butyrate

    2.3.2 Depositor-Supplied Synonyms

    1. Elagolix Sodium Salt

    2. 832720-36-2

    3. Orlissa

    4. Elagolix Sodium [usan]

    5. Nbi-56418 Na

    6. Nbi-56418-na

    7. 832720-36-2 (sodium)

    8. 5948vui423

    9. Elagolix Sodium (usan)

    10. Sodium (r)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-2,3-dihydropyrimidin-1(6h)-yl)-1-phenylethyl)amino)butanoate

    11. Chembl502182

    12. Sodium;4-[[(1r)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate

    13. Unii-5948vui423

    14. Nbi56418 Na

    15. Orilissa (tn)

    16. C32h29f5n3o5.na

    17. Schembl1641994

    18. Elagolix Sodium [who-dd]

    19. Elagolix Sodium Salt [mi]

    20. Dtxsid601003247

    21. Ex-a2388

    22. Mfcd12546649

    23. Elagolix Sodium [orange Book]

    24. Akos030524154

    25. Nbi56418; Abt-620

    26. Ccg-270333

    27. Oriahnn Component Elagolix Sodium

    28. Ac-29671

    29. As-56299

    30. Be163657

    31. Hy-14369

    32. Elagolix Sodium Component Of Oriahnn

    33. Cs-0003317

    34. D09336

    35. Q27261650

    36. 4-((r)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2h-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric Acid Sodium Salt

    37. Butanoic Acid, 4-(((1r)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2h)-pyrimidinyl)-1- Phenylethyl)amino)-, Monosodium Salt

    38. Butanoic Acid, 4-(((1r)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2h)-pyrimidinyl)-1-phenylethyl)amino)-, Monosodium Salt

    39. Sodium 4-(((1r)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6- (trifluoromethyl)phenyl)methyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2h)-yl)-1- Phenylethyl)amino)butanoate

    40. Sodium 4-(((1r)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2h)-yl)-1-phenylethyl)amino)butanoate

    2.4 Create Date
    2008-05-19
    3 Chemical and Physical Properties
    Molecular Weight 653.6 g/mol
    Molecular Formula C32H29F5N3NaO5
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count11
    Rotatable Bond Count12
    Exact Mass653.19250613 g/mol
    Monoisotopic Mass653.19250613 g/mol
    Topological Polar Surface Area102 Ų
    Heavy Atom Count46
    Formal Charge0
    Complexity1090
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 1  
    Drug NameORILISSA
    Active IngredientELAGOLIX SODIUM
    CompanyABBVIE INC (Application Number: N210450. Patents: 6872728, 7056927, 7176211, 7179815, 7419983, 7462625)

    Post Enquiry
    POST ENQUIRY